Oligo-astrocytoma in LZTR1-related Noonan syndrome

Eur J Med Genet. 2020 Jan;63(1):103617. doi: 10.1016/j.ejmg.2019.01.007. Epub 2019 Jan 19.

Abstract

Mutations in LZTR1, already known to be causal in familial schwannomatosis type 2, have been recently involved in a small proportion of patients with autosomal dominant and autosomal recessive Noonan syndrome. LZTR1 is also a driver gene in non syndromal glioblastoma. We report a 26-year-old patient with typical Noonan syndrome, and the dominantly transmitted c.850C > T (p.(Arg284Cys)) variant in LZTR1. An oligoastrocytoma was diagnosed in the patient at the age of 22 years; recurrence of the tumor occurred at age 26, as a ganglioblastoma. The patient had been transiently treated with growth hormone between ages 15 and 17. Considering the implication of LZTR1 in sporadic tumors of the nervous system, we hypothesize that gliomas are a possible complication of LZTR1-related Noonan syndrome. This report also supports a possible link between occurrence of a cerebral tumor in Noonan syndrome and a previous treatment with growth hormone.

Keywords: Glioma; Growth hormone therapy; LZTR1; Noonan syndrome.

MeSH terms

  • Adolescent
  • Adult
  • Astrocytoma / complications
  • Astrocytoma / diagnosis
  • Astrocytoma / genetics*
  • Astrocytoma / pathology
  • Female
  • Genetic Predisposition to Disease
  • Glioblastoma / complications
  • Glioblastoma / diagnosis
  • Glioblastoma / genetics*
  • Glioblastoma / pathology
  • Humans
  • Male
  • Mutation
  • Noonan Syndrome / complications
  • Noonan Syndrome / diagnosis
  • Noonan Syndrome / genetics*
  • Noonan Syndrome / pathology
  • Pedigree
  • Transcription Factors / genetics*

Substances

  • LZTR1 protein, human
  • Transcription Factors